154 related articles for article (PubMed ID: 29533545)
1. Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with anti-TNF therapy.
Kopec-Medrek M; Kucharz EJ
Adv Clin Exp Med; 2018 Mar; 27(3):383-389. PubMed ID: 29533545
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis.
Smith SL; Alexander S; Nair N; Viatte S; Eyre S; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; Plant D; Barton A
Ann Rheum Dis; 2023 May; 82(5):611-620. PubMed ID: 36810200
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.
Niki Y; Takeuchi T; Nakayama M; Nagasawa H; Kurasawa T; Yamada H; Toyama Y; Miyamoto T
PLoS One; 2012; 7(5):e37447. PubMed ID: 22629396
[TBL] [Abstract][Full Text] [Related]
4. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
Inciarte-Mundo J; Victoria Hernández M; Ruiz-Esquide V; Raquel Cabrera-Villalba S; Ramirez J; Cuervo A; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Care Res (Hoboken); 2016 Jul; 68(7):899-906. PubMed ID: 26841119
[TBL] [Abstract][Full Text] [Related]
5. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
[TBL] [Abstract][Full Text] [Related]
6. MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis.
Choi IY; Gerlag DM; Herenius MJ; Thurlings RM; Wijbrandts CA; Foell D; Vogl T; Roth J; Tak PP; Holzinger D
Ann Rheum Dis; 2015 Mar; 74(3):499-505. PubMed ID: 24297376
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Myeloid-Related Protein 8/14 as a Predictor for Biological Treatment and Disease Activity in Rheumatoid Arthritis.
Yunchun L; Yue W; Jun FZ; Qizhu S; Liumei D
Ann Clin Lab Sci; 2018 Jan; 48(1):63-68. PubMed ID: 29530998
[TBL] [Abstract][Full Text] [Related]
8. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.
Nordal HH; Brokstad KA; Solheim M; Halse AK; Kvien TK; Hammer HB
Arthritis Res Ther; 2017 Jan; 19(1):3. PubMed ID: 28081709
[TBL] [Abstract][Full Text] [Related]
9. Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis?
Benucci M; Meacci F; Manfredi M; Gobbi FL; Infantino M; Ricci C; Sarzi-Puttini P; Atzeni F
Curr Rheumatol Rev; 2014; 10(2):131-5. PubMed ID: 25599685
[TBL] [Abstract][Full Text] [Related]
10. A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients.
Nair SC; Welsing PM; Choi IY; Roth J; Holzinger D; Bijlsma JW; van Laar JM; Gerlag DM; Lafeber FP; Tak PP
PLoS One; 2016; 11(3):e0152362. PubMed ID: 27029006
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-related Protein 8/14 Levels in Rheumatoid Arthritis: Marker of Disease Activity and Response to Methotrexate.
Patro PS; Singh A; Misra R; Aggarwal A
J Rheumatol; 2016 Apr; 43(4):731-7. PubMed ID: 26834220
[TBL] [Abstract][Full Text] [Related]
12. Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.
Inciarte-Mundo J; Ruiz-Esquide V; Hernández MV; Cañete JD; Cabrera-Villalba SR; Ramirez J; Yagüe J; Sanmarti R
Rheumatology (Oxford); 2015 Dec; 54(12):2239-43. PubMed ID: 26242859
[TBL] [Abstract][Full Text] [Related]
13. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
[TBL] [Abstract][Full Text] [Related]
14. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
Jonsson MK; Sundlisæter NP; Nordal HH; Hammer HB; Aga AB; Olsen IC; Brokstad KA; van der Heijde D; Kvien TK; Fevang BS; Lillegraven S; Haavardsholm EA
Ann Rheum Dis; 2017 Dec; 76(12):2031-2037. PubMed ID: 28814431
[TBL] [Abstract][Full Text] [Related]
15. Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs.
de Moel EC; Rech J; Mahler M; Roth J; Vogl T; Schouffoer A; Goekoop RJ; Huizinga TWJ; Allaart CF; Toes REM; Schett G; van der Woude D
Arthritis Res Ther; 2019 Dec; 21(1):268. PubMed ID: 31805992
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
[TBL] [Abstract][Full Text] [Related]
17. Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis.
Szeremeta A; Jura-Półtorak A; Zoń-Giebel A; Olczyk K; Komosińska-Vassev K
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629227
[TBL] [Abstract][Full Text] [Related]
18. Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis.
Morozzi G; Fabbroni M; Bellisai F; Cucini S; Simpatico A; Galeazzi M
Clin Rheumatol; 2007 Aug; 26(8):1335-8. PubMed ID: 17285224
[TBL] [Abstract][Full Text] [Related]
19. Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis.
Van Hoovels L; Vander Cruyssen B; Bogaert L; Van den Bremt S; Bossuyt X
Clin Chem Lab Med; 2019 Dec; 58(1):40-49. PubMed ID: 31665107
[TBL] [Abstract][Full Text] [Related]
20. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]